News

Find News

Filter articles

Applied Filters

Showing 1011 to 1020 of 1033 results

Acura sues Ranbaxy over abuse-resistant generic

US01-05-2013

Acura Pharmaceuticals has sued Ranbaxy Laboratories to keep it from releasing a generic version of its immediate release tablet formulation of painkiller Oxecta.

Actavis eyes $100 million after OxyContin settlement

US29-04-2013

Generic drug-maker Actavis believes it will earn profits of around $100 million in the next two years from licensing patents owned by Purdue Pharma LP.

FTC critical of pay-for-delay in annual report

US24-04-2013

The US Federal Trade Commission has published its annual report for 2012, in which it remains critical of “pay-for-delay” patent settlements.

Shionogi sues Hospira to block Doribax generic

US19-04-2013

Japanese pharma Shionogi has brought a lawsuit against Hospira Inc to keep it from marketing a generic version of Shionogi’s Doribax, alleging it infringes one of the company’s patents.

OFT accuses GSK of market abuse over pay-for-delay deals

UK19-04-2013

The UK Office of Fair Trading has accused GlaxoSmithKline of abusing its market dominance and infringing UK competition law by paying rivals to delay releasing generic versions of its anti-depressant Seroxat.

Novartis sues three over generic Zometa

US17-04-2013

Swiss pharmaceutical firm Novartis has filed a lawsuit against Accord Healthcare, Fresenius Kabi and Hikma Farmaceutica for applying to market generic versions of its cancer drug Zometa.

USPTO names Patents for Humanity winners

US12-04-2013

The US Patent and Trademark Office has announced the winners of its Patents for Humanity competition, which recognises patent owners and licensees addressing global health and development challenges.

Merck fails to ban Indian diabetes generics

India08-04-2013

Merck is the latest multinational pharma company to suffer a setback in India, after failing to win an injunction against generic versions of two anti-diabetes drugs.

India's Novartis ruling: the implications for patent owners

India03-04-2013

India’s Supreme Court has rejected pharmaceutical company Novartis’s application to patent an updated version of its leukaemia drug Glivec, agreeing with the Comptroller General that it lacked novelty.

AstraZeneca settles Crestor patent dispute

US27-03-2013

UK pharmaceutical company AstraZeneca has reached a settlement with Actavis and Egis Pharmaceuticals that delays the release of generic versions of its cholesterol treatment Crestor.

Showing 1011 to 1020 of 1033 results

LSIPR